Grant Awards in October 2001

Preface >>
Facts and Figures >>

Principal Investigator Project Title/Link
Dr. William J. Burlingham
University of Wisconsin Medical School, Madison, USA
Delayed Type Hypersensitivity (DTH) Status and MMF Monotherapy
Dr. Christiane Ferran
Beth Israel Deaconess Medical Center, Boston, USA
Protective Effect of A20 against Transplant-Associated Vasculopathy
Prof. Edward K. Geissler
University of Regensburg, Regensburg, Germany
Paclitaxel and Rapamycin: A One-Two Punch Against Rejection and Cancer in Organ Transplantation
Dr. David A. Gerber
University of North Carolina, Chapel Hill, USA
The Immunologic Basis of Hepatic Progenitor Cell Transplantation
Prof. Michel Goldman
Université Libre de Bruxelles, Bruxelles, Belgium
Dendritic Cells Transduced with the FasL Gene as a Tool to Regulate Allograft Immunity
Dr. Michael D. Gunn
Duke University Medical Center, Durham, USA
The Role of Plasmacytoid Dendritic Cells in the Development of Tolerance
Dr. Anatolij Horuzsko
Medical College of Georgia, Augusta, USA
Prevention of Skin Allograft Rejection by HLA-G-Modified Dendritic Cells
Prof. Ian Hutchinson
University of Manchester, Manchester, UK
VEGF: A Central Mediator in both Acute and Chronic Transplant Rejection
Dr. Koichi Shimizu
Brigham & Women's Hospital, Boston, USA
Source of Intimal Smooth Muscle like Cells in Aortic Allograft Arteriopathy
Dr. Thomas Wekerle
Vienna General Hospital, Vienna, Austria
Tolerance through Hematopoietic Cell Transplantation with Costimulation Blockade